Skip to main content
. 2018 Feb 6;2018(2):CD011123. doi: 10.1002/14651858.CD011123.pub2

Comparison 5. Chemotherapy ± interleukin‐2.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
5.1 Overall survival 2 644 Hazard Ratio (IV, Random, 95% CI) 0.95 [0.82, 1.11]
5.2 Progression‐free survival 1 363 Hazard Ratio (IV, Random, 95% CI) 0.87 [0.70, 1.08]
5.3 Tumour response 3 735 Risk Ratio (M‐H, Random, 95% CI) 0.85 [0.64, 1.13]